Hepatitis B screening: Difference between revisions
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
High risk groups, such as : persons born in high or intermediate [[endemic]] areas | High risk groups, such as : persons born in high or intermediate [[endemic]] areas; persons needing [[immunosuppressive therapy]]; patients with history of [[IV]] drugs history; among others, should be tested for [[HBV infection]]. | ||
[[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age, persons with [[cirrhosis]], family history of [[HCC]], Africans over 20 years of age and any carrier over 40 years, with persistent or intermittent [[ALT]] elevation and/or high [[HBV]] [[DNA]] level >2,000 IU/mL should be screened for [[hepatocellular carcinoma]]. | [[HBV]] carriers at high risk for [[HCC]] such as Asian men over 40 years and Asian women over 50 years of age, persons with [[cirrhosis]], family history of [[HCC]], Africans over 20 years of age and any carrier over 40 years, with persistent or intermittent [[ALT]] elevation and/or high [[HBV]] [[DNA]] level >2,000 IU/mL should be screened for [[hepatocellular carcinoma]]. |
Revision as of 20:37, 29 July 2014
Hepatitis B |
Diagnosis |
Treatment |
Case Studies |
Hepatitis B screening On the Web |
American Roentgen Ray Society Images of Hepatitis B screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
High risk groups, such as : persons born in high or intermediate endemic areas; persons needing immunosuppressive therapy; patients with history of IV drugs history; among others, should be tested for HBV infection.
HBV carriers at high risk for HCC such as Asian men over 40 years and Asian women over 50 years of age, persons with cirrhosis, family history of HCC, Africans over 20 years of age and any carrier over 40 years, with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL should be screened for hepatocellular carcinoma.
Screening
Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009
The following groups should be tested for HBV infection:[1]
- Persons born in high or intermediate endemic areas
- United States– born persons not vaccinated as infants whose parents were born in regions with high HBV endemicity]
- Persons with chronically elevated aminotransferases
- Persons needing immunosuppressive therapy
- Men who have sex with men
- Persons with multiple sexual partners or history of sexually transmitted disease
- Inmates of correctional facilities
- Persons who have ever used injecting drugs, dialysis patients, HIV or HCV infected individuals, pregnant women, and family members, household members, and sexual contacts of HBV infected persons.
- Testing for HBsAg and anti-HBs should be performed, and seronegative persons should be vaccinated. (Grade I Recommendation)}}
Recommendations for HCC Screening: AASLD Practice Guidelines 2009
The following groups should be screened with US examination every 6-12 months: (Grade II-2)[1]
- HBV carriers at high risk for HCC such as Asian men over 40 years and Asian women over 50 years of age
- Persons with cirrhosis
- Persons with a family history of HCC
- Africans over 20 years of age
- Any carrier over 40 years with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL
For HBV carriers at high risk for HCC who are living in areas where US is not readily available, periodic screening with AFP should be considered. (Grade II-2)}}
References
- ↑ 1.0 1.1 Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=
ignored (help)